Literature DB >> 15780843

Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats.

William A Carlezon1, Michael L Rohan, Stephen D Mague, Edward G Meloni, Aram Parsegian, Kenroy Cayetano, Hilarie C Tomasiewicz, Elizabeth D Rouse, Bruce M Cohen, Perry F Renshaw.   

Abstract

BACKGROUND: Evidence suggests that a novel type of magnetic resonance imaging (MRI) scan called echo planar magnetic resonance spectroscopic imaging (EP-MRSI) has mood-elevating actions in humans during the depressive phases of bipolar disorder. We examined whether a low-energy component of EP-MRSI (low-field magnetic stimulation [LFMS]) has antidepressant-like, locomotor-stimulating, or amnestic effects in rats.
METHODS: We examined the effects of LFMS on immobility in the forced swim test (FST) and activity within an open field in separate groups of rats. After exposure to forced swimming, rats received LFMS (three 20-min sessions at 1.5 G/cm and .75 V/m) before behavioral testing. We also examined the effects of LFMS on fear conditioning (FC), a learning paradigm that also involves exposure to stressful conditions.
RESULTS: Low-field magnetic stimulation reduced immobility in the FST, an antidepressant-like effect qualitatively similar to that of standard antidepressants. Low-field magnetic stimulation did not alter locomotor activity or FC.
CONCLUSIONS: Low-field magnetic stimulation has antidepressant-like effects in rats that seem unrelated to locomotor-activating or amnestic effects. These findings raise the possibility that electromagnetic fields can affect the brain biology and might have physiologic consequences that offer novel approaches to therapy for psychiatric disorders. These same consequences might render MRI-based scans more invasive than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780843     DOI: 10.1016/j.biopsych.2004.12.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.

Authors:  Rachael M Youngs; Melissa S Chu; Edward G Meloni; Alipi Naydenov; William A Carlezon; Christine Konradi
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

3.  Coil design considerations for deep transcranial magnetic stimulation.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Clin Neurophysiol       Date:  2013-12-22       Impact factor: 3.708

4.  Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Authors:  Maurizio Fava; Marlene P Freeman; Martina Flynn; Bettina B Hoeppner; Richard Shelton; Dan V Iosifescu; James W Murrough; David Mischoulon; Cristina Cusin; Mark Rapaport; Boadie W Dunlop; Madhukar H Trivedi; Manish Jha; Gerard Sanacora; Gretchen Hermes; George I Papakostas
Journal:  Brain Stimul       Date:  2017-09-23       Impact factor: 8.955

5.  Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs.

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Brain Stimul       Date:  2012-03-21       Impact factor: 8.955

6.  A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).

Authors:  Marc J Dubin; Irena P Ilieva; Zhi-De Deng; Jeena Thomas; Ashly Cochran; Kamilla Kravets; Benjamin D Brody; Paul J Christos; James H Kocsis; Conor Liston; Faith M Gunning
Journal:  J Affect Disord       Date:  2019-02-14       Impact factor: 4.839

Review 7.  Epinephrine: a short- and long-term regulator of stress and development of illness : a potential new role for epinephrine in stress.

Authors:  Dona Lee Wong; T C Tai; David C Wong-Faull; Robert Claycomb; Edward G Meloni; Karyn M Myers; William A Carlezon; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2011-11-17       Impact factor: 5.046

8.  Electric field measurement of two commercial active/sham coils for transcranial magnetic stimulation.

Authors:  J Evan Smith; Angel V Peterchev
Journal:  J Neural Eng       Date:  2018-06-22       Impact factor: 5.379

Review 9.  Neuromodulation for mood and memory: from the engineering bench to the patient bedside.

Authors:  Zhi-De Deng; Shawn M McClintock; Nicodemus E Oey; Bruce Luber; Sarah H Lisanby
Journal:  Curr Opin Neurobiol       Date:  2014-09-16       Impact factor: 6.627

10.  The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.

Authors:  Andrew F Leuchter; Ian A Cook; Yi Jin; Bill Phillips
Journal:  Front Hum Neurosci       Date:  2013-02-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.